ABINGTON, Pa. (WPVI) -- To treat or not to treat? It's a common dilemma when cysts and masses are found by accident during tests for other medical conditions. A new study from Fox Chase Cancer Center ...

The presence and number of kidney cysts, particularly in the medulla, may be an additional imaging-based biomarker for progressive CKD after radical nephrectomy for kidney cancer. Among patients who ...

A compound originally developed as a cancer treatment may hold promise for treating polycystic kidney disease (ADPKD), which affects more than half a million Americans and can lead to kidney ...

Polycystic kidney disease (PKD) causes round, fluid-filled sacs called cysts to grow in your kidneys. These cysts can cause your kidneys to enlarge and function poorly. People with PKD can also ...

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the kidneys. Over time, the painful, growing cysts rob the organs of their ...

A 46-year-old man who recently moved to the area was referred to the nephrology clinic for kidney cysts. He was found to have multiple cysts in the left kidney at age 27 for which he was referred to ...

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function. The disease affects more than 12 ...

When you think of your vital organs, you probably think of your heart and lungs. But your kidneys also play a big role in how your body functions. Your two kidneys are located below your ribcage on ...

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the kidneys. Over time, the painful, growing cysts rob the organs of their ...

Liver cysts were found in over 80% of patients with ADPKD but were not associated with chronic kidney disease stage, Mayo classification, PKD1 or PKD2 genotype variant, liver enzyme levels, or quality ...

MIT researchers including Robert Croy (left) and Bogdan Fedeles have discovered that a drug they originally developed as a potential cancer treatment may also hold promise in treating autosomal ...